Nanofat injections for osteoarthritis of the jaw joint
Tests nanofat injected into the jaw joint of adults with osteoarthritis.
Key facts
- Who runs it
- Tartu University Hospital
- Where
- Estonia1 site in 1 countryChoose a country to see its sites
- Registry title
- The usage of unenriched emulsified fat transplant in temporomandibular joint degenerative diseases
- Status
- Not yet recruiting
- Phase
- Phase 2
- People taking part
- 14 people, planned
- Started
- 1 Sept 2022
- Planned end
- 31 May 2026
- Type of study
- Interventional
- Record updated
- 12 March 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with wear-and-tear arthritis of the jaw joint (TMJ OA). It tests injections of the person's own processed fat (nanofat) into the joint.
- Age
- 18-65 years in the criteria; the record's age fields say 18 Years to 64 Years.
- Sex
- All sexes can join.
- Disease stage
- Jaw joint osteoarthritis at stage 4 or 5 on the Wilkes classification.
- Earlier treatment
- At least 6 months of non-surgical (conservative) treatment that did not help. People who had surgery on the jaw joint before cannot join.
Main reasons for not taking part
- Pregnancy
- Cancer or lymphoproliferative disorders (cancers of the lymph system)
- Blood clotting disorders or diabetes
- Acute viral infections or other severe chronic or general health conditions
- Prior surgery on the jaw joint
The registry criteria, word for word
Show the criterionShow less
Who can take part
- The study plans to include patients aged 18-65 years, with TMJ OA classified as stage 4 or 5 according to the Wilkes classification (9), and who have not responded to at least 6 months of conservative treatment. Participation in the study is voluntary, and the participant may withdraw at any stage
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is to determine the effectiveness of using nanofat in the treatment of temporomandibular joint osteoarthritis (TMJ OA). The study seeks to identify correlations between the patient's subjective symptoms, clinical presentation, and radiological findings, perform data analysis, and apply the results in clinical practice.
Read full original descriptionShow less
The hypothesis of this study is that the injection of autologous nanofat into the temporomandibular joint slows the progression of degenerative changes, promotes the regeneration of the deformed joint surface, and thereby improves the quality of life for patients.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- The usage of unenriched emulsified fat transplant in temporomandibular joint degenerative diseases
- Plain-language title
- Nanofat injections for osteoarthritis of the jaw jointGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from 2024-520244-41-00, who can take part
- Record updated
- 12 March 2025